Internal Medicine
Partner With Us
Advertisement

Oncology & Hematology

thumb description

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

thumb description

December 13, 2024

Large Study Reveals Melanoma's Hidden Risks

Analysis of over 280,000 melanoma patients reveals these survivors face significantly elevated risks of developing 12 different types of second primary cancers, with the risk being particularly pronounced in younger patients and those with thicker tumors.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.